Mursla’s AI Precision Medicine is built on the ability to isolate and analyze EVs which are secreted by specific organs into ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial ...

With tremendous social and economic costs, dementia is now the seventh leading cause of death globally, affecting 57 million ...

Nucleic acid immunity involves a sophisticated set of mechanisms for identifying nucleic acids by immune receptors, playing a vital role in physiological ...

Advances in the speed, scale, and affordability of nucleic acid synthesis over the last two decades have catalyzed a rapidly evolving landscape in ...

Nucleic acids (DNA or RNA) are polymers of nucleotides – each nucleotide consists of a pentose sugar, a phosphate group and one of the nitrogenous bases (purines and pyrimidines). Nucleic acids ...

The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23 ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

Both AlphaFold 3 and Boltz-1 were trained on the protein data bank (PDB), the public repository housing more than 200,000 entries for experimentally determined protein and nucleic acid structure data.

A resident takes a COVID-19 nucleic acid test at a testing point in Beijing, May 26, 2022. [Photo/VCG] There are signs indicating that having a nucleic acid test will become a routine part of life of ...

The resulting organosilica nanoparticles contain nucleic acid structures that can respond to physical stimuli (e.g., temperature) and can recognize complementary NA strands or small molecules (e.g., .